Cancerworld Magazine
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnerships
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
SUBSCRIBE FOR FREE
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnerships
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
Cancerworld Magazine > Partnerships > European Cancer Organisation > ECO welcomes draft new EU recommendations on cancer screening

ECO welcomes draft new EU recommendations on cancer screening

  • 20 September 2022
  • European Cancer Organisation
ECO welcomes draft new EU recommendations on cancer screening
Total
0
Shares
0
0
0
0
0

Brussels, 20 September 2022: The European Commission today published new, more ambitious proposals for cancer screening across Europe. As part of its Beating Cancer Plan, the recommendations should help EU countries expand coverage so that 90% of the EU population that qualifies for breast, cervical and colorectal cancer screenings would be offered the tests by 2025. Although the new proposals are not legally binding on Member States, they offer important guidance on achieving these critical targets.

The European Cancer Organisation (ECO) welcomes today’s publication, including suggestions on how to expand screening for three cancers while adding coverage for other cancers such as prostate, lung and gastric cancer.

From Professor Andreas Charalambous, President of the European Cancer Organisation:

“The European Cancer Organisation was pleased to bring its member societies, patient organisations and many others to a consensus position on cancer screening and early detection via its 2021 paper ‘Earlier is Better’. Our paper made a strong case for updating the recommendations for breast, colorectal and cervical cancer, and to expand coverage to new tumour types. Beyond screening, we must not forget the opportunities for improving early detection of all cancer types through new technologies and practices, such as AI, liquid biopsy, genetic and genomic technologies, and increased public awareness of the early warning signs.”

From Dr Isabel Rubio, Co-Chair of the ECO Prevention, Early Detection and Screening Network:

“Since 2003, the world of screening and early detection has advanced considerably. This includes targeting more cancers, the introduction of new technologies and practices, and the improvement of validated risk prediction models in cancer screening. It is welcome news that new recommendations to EU Member States reflect these changes and encourage all countries to bring their cancer screening approaches up to date with the latest evidence. The challenge now is ensuring a robust implementation and monitoring framework to turn words into action.”

From Prof Jan van Meerbeeck, Co-Chair of the ECO Prevention, Early Detection and Screening Network:

“What is so encouraging about the Commission’s proposed update is the time that was taken to hear from – and reflect on – evidence from leading European experts. The case for introducing additional screening programmes to the recommendations, such as for lung, prostate, and gastric cancer, has been much needed and the European cancer community is gratified to see their inclusion in the Commission’s proposal. Earlier detection will save thousands of lives. It’s a moral imperative now to assist countries in bringing the recommendations into reality.”

Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
External Contributor

You May Also Like
View Post
  • News

Improving outcomes in elderly patients taking multiple medications

  • Janet Fricker
  • 24 March 2023
View Post
  • News

Localised prostate cancer: active monitoring offers valid option

  • Janet Fricker
  • 24 March 2023
View Post
  • Articles
  • Delivery of Care

‘Fragile’ cancer patients hit by Turkish earthquake need urgent support

  • Marwa Koçak
  • 22 March 2023
View Post
  • Articles
  • Delivery of Care

Expert cancer surgery: could VR help speed up and standardise training?

  • Simon Crompton
  • 22 March 2023
View Post
  • Articles
  • Medicine

Immunotherapy: three studies point to potential strategies to improve response

  • Janet Fricker
  • 10 March 2023
View Post
  • Articles
  • Biology basic

A blood test for early detection of any cancer: What’s the ideal? Are we getting there?

  • Rachel Brazil
  • 10 March 2023
View Post
  • News

Radiotherapy can be safely omitted in older women with low-risk breast cancer

  • Janet Fricker
  • 10 March 2023
View Post
  • News

Plant-based diets cut risk of prostate cancer progression and recurrence by over 50%

  • Janet Fricker
  • 9 March 2023
search
or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • Improving outcomes in elderly patients taking multiple medications
    • 24 March 2023
  • Localised prostate cancer: active monitoring offers valid option
    • 24 March 2023
  • Radiotherapy can be safely omitted in older women with low-risk breast cancer
    • 10 March 2023
  • Plant-based diets cut risk of prostate cancer progression and recurrence by over 50%
    • 9 March 2023
  • A blood test to recognize prostate cancer
    New prostate cancer blood test combining PSA with epigenetic test could reduce biopsies
    • 23 February 2023
Article
  • ‘Fragile’ cancer patients hit by Turkish earthquake need urgent support
    • 22 March 2023
  • Expert cancer surgery: could VR help speed up and standardise training?
    • 22 March 2023
  • Immunotherapy: three studies point to potential strategies to improve response
    • 10 March 2023
Latest printed issue
Social

Would you follow us ?

Contents
  • AI in Surgery
    • 8 March 2023
  • COVID and haematological malignancies
    • 28 February 2023
  • Telemedicine Rehabilitation in the Cancer Care Continuum
    • 24 February 2023
MENU
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnerships
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
Cancerworld Magazine
  • About the Magazine
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is published by SPCC Sharing Progress in Cancer Care | Via Vincenzo Vela 6, 6500 Bellinzona - Switzerland | info@spcc.net

Archivio Cancerworld

Input your search keywords and press Enter.